RecruitingNCT07265544

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease


Sponsor

Nanfang Hospital, Southern Medical University

Enrollment

240 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this observational study is to employ single-cell multi-omics and spatial omics technologies to characterize the spatial and immune structures within the livers of patients with fatty liver, hepatic hemangioma, focal nodular hyperplasia, liver fibrosis, cirrhosis, and HBV infection. The primary questions it aims to address are: Investigate the mechanisms of liver degenerative changes during the processes of liver aging, fatty liver, HBV infection, liver fibrosis, and cirrhosis. Characterize the molecular features and cellular networks at different stages of liver degeneration and identify new targets and mechanisms for the cure of the aforementioned diseases. The study will collect peripheral blood and discarded liver tissue from patients with hepatic hemangioma, fatty liver, HBV infection, liver fibrosis, and cirrhosis who are undergoing hepatectomy or liver biopsy.


Eligibility

Plain Language Summary

Simplified for easier understanding

This research study is using advanced laboratory techniques (single-cell and spatial analysis) to better understand how liver diseases develop and progress — from fatty liver to fibrosis and cirrhosis. Researchers are collecting liver tissue samples from patients having surgery or biopsies for various liver conditions. This is not a treatment trial. **You may be eligible if...** - You have been diagnosed with a liver condition such as a liver hemangioma (a benign blood vessel growth), focal nodular hyperplasia, fatty liver, hepatitis B infection, liver fibrosis, or cirrhosis - You are already scheduled for liver surgery or a liver biopsy for clinical reasons - There are no age or gender restrictions **You may NOT be eligible if...** - You have HIV infection - You have a blood clotting disorder such as hemophilia - You have a serious underlying illness that affects your immune system Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECollection of Preoperative Peripheral Blood

Prior to surgery, 30 milliliters of peripheral blood will be drawn from the subject's upper limb.

PROCEDURECollection of Discarded Liver Tissue During Surgery

From subjects undergoing hepatectomy or liver biopsy, discarded liver tissue will be collected during the surgical procedure.


Locations(1)

Nan

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07265544


Related Trials